DLBCL - Diffuse Large B Cell Lymphoma: Clinical Trials

2 trials for DLBCL - Diffuse Large B Cell Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 recruiting. 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 12Not yet recruiting 1, Recruiting 1

Follow DLBCL - Diffuse Large B Cell Lymphoma: new trials by email Literature Review of DLBCL - Diffuse Large B Cell Lymphoma trials Research Report on DLBCL - Diffuse Large B Cell Lymphoma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Study Exploring the Safety, Efficacy and Metabolic Kinetics of CT1182 Injection in Patients With Relapsed / Refractory Non Hodgkin Lymphoma
CT1182 injection - B-cell Non Hodgkin Lymphoma (NHL), DLBCL - Diffuse Large B Cell Lymphoma
Early Phase 1RecruitingUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology242026-04-302026-04-23
ImmunoMRI for Assessment of Tumor-associated Macrophages
MRI contrast-enhancing agents - DLBCL - Diffuse Large B Cell Lymphoma
Early Phase 1Not yet recruitingMedical University of Vienna602025-10-012025-07-15

Narrower conditions

Dendritic Cell Sarcoma, Interdigitating (2)  ·  Lymphoma, B-Cell (1)  ·  Lymphoma, Follicular (1)

Broader conditions

Hemic and Lymphatic Diseases (2)  ·  Histiocytic Disorders, Malignant (2)  ·  Histiocytosis (2)  ·  Lymphatic Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoproliferative Disorders (1)

Sponsors

Medical University of Vienna (1)  ·  Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)

Countries

Austria (1)  ·  China (1)

Top investigators

Marius E Mayerhoefer, MD, PhD (1)